| 12 May 2005
Northbank’s financial communications practice expands further
With York Pharma and CeNeS Pharmaceuticals recently signed up as new clients, Northbank’s financial communications practice is off to a good start in 2005. These companies, which are both AIM listed, are focused on the treatment of dermatological and CNS disorders respectively.
These new clients join Physiomics, the European systems biology company, which floated on AIM in December 2004, as part of Northbank’s growing financial communications practice.
Emma Palmer, Associate Director and Head of Financial Communications at Northbank, said, “We are delighted to welcome York and CeNeS to Northbank and look forward to supporting their communications activities as the companies grow and develop. In addition, congratulations are due to Plethora Solutions, another Northbank client, which recently floated on AIM”.
back
to news
|
